More top executives leaving Alexion Pharmaceuticals

NEW HAVEN, Conn. (WTNH) — Earlier this week, the New Haven-based company announced the Chief Financial Officer is leaving along with the Head of Research and Development, the head of HR and the Top Compliance Officer.

This follows the departure of Alexion’s CEO in December. Alexion moved into their New Haven headquarters less than a year ago.

Mayor Toni Harp says she is optimistic they will right the ship.

“You know, every company is going to have growing pains. It grew rapidly and I think now is going to go through a period where it will have a bit of a downturn and it will stabilize,” she said.

Alexion makes drugs that treat rare diseases. Their stock has taken a hit as of late Thursday. It closed down at $98.50 per share, down sharply from the 2017 high of $144 in January.

WTNH NEWS8 provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review. Also, you can now block any inappropriate user by simple selecting the drop down menu on the right of any comment and selection "Block User" from there.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s